Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × tislelizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Recurrence 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Locally Advanced or Metastatic Urothelial Bladder Cancer 1 Locally Advanced and Metastatic Solid Tumors 1 Limited Stage Small Cell Lung Cancer 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 binimetinib 12 Paclitaxel 12 Introns 12 Interferon alpha-2 12 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 montanide ISA 51 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡